entertainment -WSS

entertainment

author：explore 2025-09-27 12:35:37 - browse：79

George Yancopoulos on the 2024 Breakthrough Summit East stage. — George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

George Yancopoulos is in touch with his teenage self.

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

“My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Brain injuries and the importance of a second opinion

WSS

FDA seeking to stop procedures at two unregulated stem cell clinics

A Theranos scientist

House passes resolution saying Israel isn't a 'racist or apartheid state'

Kidney transplant patients stopped immunosuppressants in trial

Brain injuries and the importance of a second opinion

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

hotspot

entertainment

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

FDA seeking to stop procedures at two unregulated stem cell clinics

Peter Hotez and the public health issue of online harassment

Biden administration sends mixed signals on US soldier who crossed into North Korea

Cancer drug shortages should be causing more outrage

Bill would allow buprenorphine prescription for addiction via telehealth

State Dept. review finds Biden bears some blame for Afghanistan failures

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

23andMe had bad news about my health. I wish a person had delivered it

Bill would allow buprenorphine prescription for addiction via telehealth

hotspot

How neuroscience research could help beat back brain cancer

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Infant mortality in U.S. rose last year for first time in decades: CDC

Key Senate panel to consider PBM, drug pricing reform package

Inari Medical to buy amputation prevention company LimFlow

The health care issue Democrats can’t solve: hospital reform

focus

focus

explore

leisure time